JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
102 hedge funds and large institutions have $207M invested in Jounce Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 21 increasing their positions, 40 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
102
Holders Change
+12
Holders Change %
+13.33%
% of All Funds
2.06%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
24
Increased
21
Reduced
40
Closed
12
Calls
$1.72M
Puts
$1.54M
Net Calls
+$179K
Net Calls Change
-$332K
